Product
BOS172738
Name
BOS172738
1 clinical trial
1 drug
1 indication
Indication
Advanced Nonhaematologic MalignanciesDrug
BOS172738Clinical trial
A Phase 1 Study of BOS172738 in Patients With Advanced Solid Tumors With RET Gene Alterations Including Non-Small Cell Lung Cancer (NSCLC) and Medullary Thyroid Cancer (MTC)Status: Completed, Estimated PCD: 2023-09-26